文献速递肝胆胰外科围术期管理与 ERAS

肝转移神经内分泌肿瘤减瘤术中肝切除数量与并发症的关联:ACS NSQIP数据库研究

Number of Hepatic Resections and Association with Complication after Metastatic Neuroendocrine Tumor Debulking: An American College of Surgeons NSQIP Database Study.
PubMed 文献 · J Am Coll Surg · 2023-04-04

该研究基于美国外科医师学会NSQIP靶向肝切除 Participant User File(2014—2020年)分析1,163例神经内分泌肿瘤肝转移减瘤手术患者,按肝切除数量分为1~5、6~10和>10组。总体并发症率35%,死亡率0.9%;>10次肝切除与任何并发症和手术并发症显著升高独立相关,且医疗并发症和住院时间>5天风险也增加。

要点

  • >10次肝切除是任何并发症和手术并发症的独立危险因素。
  • >10次肝切除组输血相关出血发生率显著更高。
  • 总体死亡率低(0.9%),但切除数量增多与住院时间延长相关。

核心结论

  • NSQIP数据显示神经内分泌肿瘤肝转移减瘤手术总体安全、死亡率低,但肝切除数量增多尤其是>10次与术后并发症和住院时间增加相关。

研究设计与样本

  • 回顾性队列分析,使用美国外科医师学会NSQIP靶向肝切除特异性Participant User File 2014—2020年数据,共纳入1,163例患者。
  • 按肝切除数量分为1~5次(1,011例,87%)、6~10次(101例,8.7%)和>10次(51例,4.4%)三组。
  • 采用多因素logistic回归和匹配方法识别并发症的预后因素。

主要发现

  • 总体并发症率为35%,手术并发症和医疗并发症分别为30%和13%,死亡11例(0.9%)。
  • >10次切除组任何并发症率(1~5次 vs 6~10次 vs >10次:34% vs 35% vs 53%,p=0.021)和手术并发症率(29% vs 28% vs 49%,p=0.007)显著更高。
  • >10次切除组「需要输血的出血」发生率显著更高(p<0.0001)。
  • 多因素回归中,与1~5次切除相比,>10次切除是任何并发症(OR 2.53,p=0.002)和手术并发症(OR 2.53,p=0.003)的独立危险因素。

临床怎么用

  • 对神经内分泌肿瘤肝转移拟行减瘤手术者,若预期肝切除数量>10次,应充分评估并发症风险并加强围术期管理。
  • 术前应与患者沟通切除数量增多相关的并发症和住院时间延长风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neuroendocrine tumor liver metastases (NELM) are a major source of morbidity and mortality in neuroendocrine tumor patients and can be treated with hepatic debulking surgery (HDS). This study aims to identify variables associated with postoperative morbidity in NELM HDS. STUDY DESIGN: This analysis uses the American College of Surgeons NSQIP targeted hepatectomy-specific Participant User File from 2014 to 2020. Surgeries were grouped by number of hepatic resections performed (1 to 5, 6 to 10, greater than 10). Multivariable logistic regression and matching were used to identify prognostic factors of morbidity. RESULTS: A total of 1,163 patients were included. A total of 1,011 (87%) had 1 to 5 hepatic resections, 101 (8.7%) had 6 to 10 resections, and 51 (4.4%) had greater than 10 resections. The overall complication rate was 35%, and surgical and medical complications reached 30% and 13%, respectively. Mortality occurred in 11 patients (0.9%). Significantly higher rates of any (34% vs 35% vs 53%, p = 0.021) and surgical complications (29% vs 28% vs 49%, p = 0.007) were noted for those undergoing greater than 10 resections (1 to 5 resections, 6 to 10, greater than 10). "Bleeding requiring transfusion" (p < 0.0001) occurred more frequently in the greater than 10 resection group. On multivariable logistic regression, greater than 10 resections were an independent risk factor for any (odds ratio [OR] 2.53, p = 0.002; OR 2.52, p =. 0013) and surgical (OR 2.53, p = 0.003; OR 2.88, p = 0.005) complications compared with 1 to 5 resections and 6 to 10 resections, respectively. Medical complications (OR 2.34, p = 0.020) and length of stay greater than 5 days (OR 1.98, p = 0.032) were also increased with greater than 10 vs 1 to 5 resections. CONCLUSIONS: As reported by NSQIP, NELM HDS were performed safely with low mortality. However, more hepatic resections, especially greater than 10, were associated with increased postoperative morbidity and length of stay.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Schwarz JL, Kuchta KM, Rojas A, et al. Number of Hepatic Resections and Association with Complication after Metastatic Neuroendocrine Tumor Debulking: An American College of Surgeons NSQIP Database Study. J Am Coll Surg. 2023. PMID: 37022773. doi:10.1097/XCS.0000000000000701

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。